A detailed history of Raymond James & Associates transactions in Cigna Corp stock. As of the latest transaction made, Raymond James & Associates holds 860,050 shares of CI stock, worth $282 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
860,050
Previous 602,339 42.79%
Holding current value
$282 Million
Previous $199 Million 49.64%
% of portfolio
0.18%
Previous 0.13%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$319.12 - $367.1 $82.2 Million - $94.6 Million
257,711 Added 42.79%
860,050 $298 Million
Q2 2024

Jul 19, 2024

BUY
$330.57 - $364.08 $6.19 Million - $6.82 Million
18,733 Added 3.21%
602,339 $199 Million
Q1 2024

Apr 22, 2024

BUY
$297.82 - $363.34 $7.36 Million - $8.98 Million
24,708 Added 4.42%
583,606 $212 Million
Q4 2023

Jan 16, 2024

SELL
$257.49 - $318.89 $1.61 Million - $1.99 Million
-6,242 Reduced 1.1%
558,898 $167 Million
Q3 2023

Oct 24, 2023

BUY
$268.69 - $299.4 $34 Million - $37.9 Million
126,604 Added 28.87%
565,140 $162 Million
Q2 2023

Jul 25, 2023

BUY
$242.64 - $280.6 $17.2 Million - $19.9 Million
70,775 Added 19.24%
438,536 $123 Million
Q1 2023

Apr 14, 2023

SELL
$254.03 - $321.4 $17 Million - $21.5 Million
-66,930 Reduced 15.4%
367,761 $94 Million
Q4 2022

Feb 08, 2023

BUY
$285.73 - $339.09 $4.12 Million - $4.89 Million
14,418 Added 3.43%
434,691 $144 Million
Q3 2022

Oct 25, 2022

SELL
$264.84 - $294.15 $6.35 Million - $7.06 Million
-23,992 Reduced 5.4%
420,273 $117 Million
Q2 2022

Aug 12, 2022

BUY
$242.23 - $272.4 $12.4 Million - $13.9 Million
51,075 Added 12.99%
444,265 $117 Million
Q1 2022

May 11, 2022

BUY
$217.56 - $245.83 $7.2 Million - $8.14 Million
33,117 Added 9.2%
393,190 $94.2 Million
Q4 2021

Feb 08, 2022

BUY
$191.9 - $231.65 $4.78 Million - $5.77 Million
24,924 Added 7.44%
360,073 $82.7 Million
Q3 2021

Nov 02, 2021

BUY
$200.16 - $238.3 $13.5 Million - $16 Million
67,255 Added 25.11%
335,149 $67.1 Million
Q2 2021

Aug 11, 2021

BUY
$231.97 - $266.91 $7.25 Million - $8.34 Million
31,238 Added 13.2%
267,894 $63.5 Million
Q1 2021

May 14, 2021

SELL
$203.27 - $247.55 $5.04 Million - $6.14 Million
-24,786 Reduced 9.48%
236,656 $57.2 Million
Q4 2020

Feb 12, 2021

BUY
$163.4 - $221.11 $4.38 Million - $5.93 Million
26,807 Added 11.42%
261,442 $54.4 Million
Q3 2020

Nov 04, 2020

BUY
$160.5 - $190.5 $1.02 Million - $1.21 Million
6,347 Added 2.78%
234,635 $39.8 Million
Q2 2020

Jul 28, 2020

BUY
$163.84 - $215.84 $1.45 Million - $1.91 Million
8,836 Added 4.03%
228,288 $42.8 Million
Q1 2020

Apr 21, 2020

SELL
$130.06 - $222.56 $67,631 - $115,731
-520 Reduced 0.24%
219,452 $38.9 Million
Q4 2019

Feb 12, 2020

SELL
$147.19 - $206.47 $2.57 Million - $3.61 Million
-17,491 Reduced 7.37%
219,972 $45 Million
Q3 2019

Nov 07, 2019

SELL
$146.27 - $179.96 $464,699 - $571,732
-3,177 Reduced 1.32%
237,463 $36 Million
Q2 2019

Aug 06, 2019

BUY
$145.49 - $169.13 $666,926 - $775,291
4,584 Added 1.94%
240,640 $37.9 Million
Q1 2019

May 06, 2019

SELL
$159.69 - $199.81 $4.74 Million - $5.93 Million
-29,654 Reduced 11.16%
236,056 $38 Million
Q4 2018

Feb 11, 2019

BUY
$178.01 - $224.84 $47.3 Million - $59.7 Million
265,710 New
265,710 $50.5 Million

Others Institutions Holding CI

About Cigna Corp


  • Ticker CI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 305,116,000
  • Market Cap $100B
  • Description
  • Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health c...
More about CI
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.